Open original FDA record ↗Recall record
- FDA identifier
- Z-1613-2026
- Company in FDA record
- Olympus Corporation of the Americas
- FDA classification date
- Mar 20, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The MAJ-1443 and MAJ-1444 are no longer reprocessing compatible with the OER-Pro and OER-Elite automated endoscope reprocessors.
Source facts
- Action
- Olympus notified consignees on about 02/12/2026 via URGENT: MEDICAL DEVICE CORRECTION letter. Consignees were instructed to immediately cease reprocessing the MAJ-1443 and MAJ-1444 valves in an OER-Pro or OER-Elite and ensure all personnel are completely knowledgeable and thoroughly trained on the content of this notification and the full extent of the MAJ-1443 and MAJ-1444 reprocessing steps as detailed in the provided Instructions for Use (IFU). The updated IFU can also be accessed electronically through OlympusConnect.com. Additionally, consignees were instructed to replace any existing copies of the MAJ-1443/MAJ-1444 IFU with the updated IFU provided in this letter, identify and notify all customers if affected units were further distributed and complete and confirm receipt of the notification via the Olympus web portal.
- Initiated
- 2026-02-12
- Root cause
- Reprocessing Controls
- Distribution
- US Nationwide distribution.
- Recall number
- Z-1613-2026
- Recall status
- Open, Classified
- CDRH record ID
- 218482
- FDA classified
- 2026-03-20
- Recall event number
- 98371